Circassia Pharmaceuticals PLC  

(Public, LON:CIR)   Watch this stock  
Find more results for Charles L. Cummings
May 27 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
Range     -
52 week 246.00 - 322.75
Open     -
Vol / Avg. 0.00/241,424.00
Mkt cap 820.48M*
P/E     -
Div/yield     -
EPS -0.21*
Shares 284.89M
Beta     -
Inst. own     -

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -18.19% -29.43%
Return on average equity -18.82% -31.81%
Employees 63 -
CDP Score - -


The Magdalen Centre Robert Robinson Avenue The Oxford Science Park
United Kingdom - Map
+44-1865-405560 (Phone)
+44-1865-784576 (Fax)

Website links

External links

Analyst Estimates - BusinessWeek
Options - MarketWatch
Director Dealings - Yahoo Finance


Circassia Pharmaceuticals plc is a United Kingdom-based specialty biopharmaceutical company. The Company is focused on the development and commercialization of a range of immunotherapy products for the treatment of allergies such as cat, grass, house dust mite and ragweed. The Company’s product portfolio is designed to treat a broad range of seasonal and perennial allergies. The Company’s product portfolio includes Cat-SPIRE, House Dust Mite-SPIRE, Grass-SPIRE, Ragweed-SPIRE, Birch-SPIRE, Japanese Cedar-SPIRE and Alternaria-SPIRE.

Officers and directors

Francesco Granata M.D. Non-Executive Chairman of the Board
Age: 64
Steven Harris Chief Executive Officer, Executive Director
Age: 48
Julien Cotta Chief Financial Officer, Executive Director
Age: 51
Rod Hafner Senior Vice President - Research & Development, Executive Director
Age: 49
Steve Pawsey Chief Medical Officer
Russell Cummings Non-Executive Director
Age: 50
Paul R. Edick Non-Executive Director
Age: 60
Cathrin Petty Non-Executive Director
Age: 41
Charles Swingland Non-Executive Director
Age: 62
Tim Corn Non-Executive Independent Director
Age: 63